A simple method to detect biotin interference on immunoassays

Clinical Chemistry and Laboratory Medicine

Volumn 55, Issue 6, 2017, Pages e104-e106

  Lam, Leo ^a   Kyle, Campbell V ^a,b  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b Department of Biochemistry ^*  (New Zealand)

Author keywords

biotin; endocrinology; hyperthyroidism; immunoassay; interference; streptavidin

Indexed keywords

BIOTIN; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PROGESTERONE; STREPTAVIDIN; THYROTROPIN;

ANTIGEN ANTIBODY COMPLEX; CLINICAL LABORATORY; ENDOCRINOLOGIST; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GOOD MANUFACTURING PRACTICE; HAIR LOSS; HUMAN; IMMUNOASSAY; LETTER; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REPRODUCTION; ROOM TEMPERATURE; THYROID FUNCTION TEST;

BIOTIN; HUMANS; IMMUNOASSAY; STREPTAVIDIN;

EID: 85019075239     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2017-0059     Document Type: Letter

References (9)

1. Batista MC, Ferreira CE, Faulhaber AC, Hidal JT, Lottenberg SA, Mangueira CL. Biotin interference in immunoassays mimicking subclinical Graves' disease and hyperestrogenism: a case series. Clin Chem Lab Med 2017;55:e99-103.
2. Tourbah A, Lebrun-Frenay C, Edan G, Clanet M, Papeix C, Vukusic S, et al. MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: a randomised, double-blind, placebo-controlled study. Mult Scler 2016;22:1719-31.
3. Kummer S, Hermsen D, Distelmaier F. Biotin treatment mimicking graves' disease. N Engl J Med 2016;375:704-6.
4. Wijeratne NG, Doery JC, Lu ZX. Positive and negative interference in immunoassays following biotin ingestion: a pharmacokinetic study. Pathology 2012;44:674-5.
5. Meany DL, Jan de Beur SM, Bill MJ, Sokoll LJ. A case of renal osteodystrophy with unexpected serum intact parathyroid hormone concentrations. Clin Chem 2009;55: 1737-9.
6. Diamandis EP, Christopoulos TK. The biotin-(strept)avidin system: principles and applications in biotechnology. Clin Chem 1991;37:625-36.
7. Elston MS, Sehgal S, Du Toit S, Yarndley T, Conaglen JV. Factitious Graves' disease due to biotin immunoassay interference-a case and review of the literature. J Clin Endocrinol Metab 2016;101:3251-5.
8. Trambas CM, Sikaris KA, Lu ZX. A caution regarding high-dose biotin therapy: misdiagnosis of hyperthyroidism in euthyroid patients. Med J Aust 2016;205:192.
9. Mattman A, DeMarco ML, Wong S, Holmes DT, Lee J. Grave clinicopathologic correlation: a case of hyperthyroxinemia. J Appl Lab Med 2016;1:310-14.